triazoles has been researched along with melphalan in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Helenglass, G; Jones, A; Milliken, S; Powles, R | 1 |
| Ara, G; Chen, YN; Holden, SA; Korbut, TT; Northey, D; Teicher, BA | 1 |
| Babu, H; Jiang, J; Kagan, VE; Kai, M; Kini, V; Kusumoto, C; Matsura, T; Yamada, K | 1 |
| Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J | 1 |
| Bauer, AA; Cubitt, CL; Cui, Y; Dalton, WS; Dawson, JL; Gomez, JA; Kim, J; Nishihori, T; Sullivan, DM; Turner, JG | 1 |
| Banerjee, A; Berdeja, JG; Deraedt, W; Diels, J; Jackson, CC; Jagannath, S; Krishnan, A; Martin, T; Nesheiwat, T; Schecter, JM; Usmani, SZ; Valluri, S; Van Sanden, S; Vogel, M; Weisel, K; Yalniz, F; Yeh, TM | 1 |
1 trial(s) available for triazoles and melphalan
| Article | Year |
|---|---|
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HOR
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Hydrazines; Melphalan; Multiple Myeloma; Triazoles | 2022 |
5 other study(ies) available for triazoles and melphalan
| Article | Year |
|---|---|
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Administration Schedule; Female; Fluconazole; Humans; Male; Melphalan; Middle Aged; Mycoses; Transplantation, Autologous; Triazoles; Whole-Body Irradiation | 1989 |
CAI: effects on cytotoxic therapies in vitro and in vivo.
Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carmustine; Cisplatin; Cyclophosphamide; Fibrosarcoma; Mammary Neoplasms, Experimental; Melphalan; Mice; Triazoles; Tumor Cells, Cultured | 1994 |
Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Catalase; Cytochromes c; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Melphalan; Mitochondria; Oxidation-Reduction; Phosphatidylserines; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase; Triazoles; Tumor Cells, Cultured | 2004 |
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Exportin 1 Protein; Fanconi Anemia Complementation Group D2 Protein; Humans; Hydrazines; Karyopherins; Melphalan; Mice, Inbred NOD; Multiple Myeloma; Nestin; Receptors, Cytoplasmic and Nuclear; Triazoles; Ubiquitination; Xenograft Model Antitumor Assays | 2020 |